| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
150,744 |
134,873 |
$11.47M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
129,824 |
116,994 |
$6.79M |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
82,790 |
74,704 |
$6.44M |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
55,840 |
49,832 |
$6.35M |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
24,810 |
23,149 |
$2.60M |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
50,943 |
47,024 |
$1.43M |
| 99051 |
|
147,315 |
136,108 |
$832K |
| 87631 |
|
7,653 |
7,266 |
$743K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
12,912 |
11,749 |
$728K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
26,700 |
25,055 |
$714K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
15,114 |
13,262 |
$519K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
11,185 |
10,687 |
$458K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
13,028 |
11,709 |
$419K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
10,018 |
8,596 |
$166K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
15,871 |
14,793 |
$146K |
| 81025 |
|
8,230 |
7,706 |
$40K |
| 87428 |
|
145 |
125 |
$7K |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
134 |
112 |
$6K |
| 71046 |
Radiologic examination, chest; 2 views |
313 |
264 |
$4K |
| 99205 |
Prolong outpt/office vis |
14 |
13 |
$2K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
145 |
88 |
$2K |
| 94760 |
|
860 |
827 |
$1K |
| 90674 |
|
86 |
48 |
$1K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
128 |
93 |
$708.41 |
| 81003 |
|
19,424 |
17,922 |
$493.97 |
| 93000 |
|
41 |
28 |
$342.49 |
| 36415 |
Collection of venous blood by venipuncture |
125 |
121 |
$341.20 |
| 82962 |
|
166 |
161 |
$292.90 |
| 36416 |
|
41 |
40 |
$109.20 |
| 94761 |
|
27 |
25 |
$74.88 |
| 99000 |
|
6,086 |
5,710 |
$58.21 |
| 99441 |
|
42 |
40 |
$53.08 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
24 |
14 |
$1.87 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
34 |
21 |
$0.81 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
120 |
60 |
$0.00 |
| 85018 |
|
12 |
12 |
$0.00 |